{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260427182040/en/U.S.-FDA-Grants-Priority-Review-of-New-Drug-Application-for-Gilead%E2%80%99s-Once-Daily-HIV-Treatment-of-Bictegravir-Plus-Lenacapavir", "message": "News view counter 688619 successfully enlarged"}